Posted on March 30: McMaster forms alliance with CELLutions Biosystems

McMaster has signed a key strategic alliance with Toronto-based biotechnology company CELLutions Biosystems, Inc. Through this partnership, CELLutions will acquire the exclusive rights to market and distribute selected novel cell lines and other innovative biological reagents developed by researchers at McMaster.

CELLutions focuses on the commercialization, marketing, and distribution of innovative cell lines and other research tools for use in basic science, drug discovery, and therapeutic development.

“We are very excited about the potential benefits that this strategic partnership will bring to our institution and its researchers,” says Mamdouh Shoukri, vice-president of research at McMaster University. “We are looking forward to developing this relationship and working together with CELLutions to identify promising scientists and research projects whose work has, or will develop unique cell lines, as well as other research tools that have innate value to the biopharmaceutical industry.”

“It is our goal through our partnership with McMaster to build upon the tremendous early success of CELLutions,” says Michael Wasserman, vice-president, business development for CELLutions. “We are working diligently to create a world-class Canadian organization with the ability to bring cutting-edge technology from Canada's leading academic institutions into widespread use in biopharmaceutical research and development programs around the world. We intend to use this alliance as a catalyst for further collaborations, with the intent of building a company with the critical technology mass to compete on a global scale.”

CELLutions will create and implement targeted marketing strategies to maximize the impact of these high potential technologies, and products will be made available to research groups in both the academia and biopharmaceutical industry.

Republish this Article for Free

Republish this Article

We believe in the free flow of information. This work is licensed under a Creative Commons Attribution-No Derivs 2.5 Canada (CC BY-ND 2.5 CA), so you can republish our articles for free, online or in print.

All republished articles must be attributed in the following way and contain links to both the site and original article: “This article was first published on Daily News. Read the original article.”

McMaster has signed a key strategic alliance with Toronto-based biotechnology company CELLutions Biosystems, Inc. Through this partnership, CELLutions will acquire the exclusive rights to market and distribute selected novel cell lines and other innovative biological reagents developed by researchers at McMaster.<p><br />
<br />
CELLutions focuses on the commercialization, marketing, and distribution of innovative cell lines and other research tools for use in basic science, drug discovery, and therapeutic development.<p><br />
<br />
"We are very excited about the potential benefits that this strategic partnership will bring to our institution and its researchers," says Mamdouh Shoukri, vice-president of research at McMaster University.  "We are looking forward to developing this relationship and working together with CELLutions to identify promising scientists and research projects whose work has, or will develop unique cell lines, as well as other research tools that have innate value to the biopharmaceutical industry."<p><br />
<br />
"It is our goal through our partnership with McMaster to build upon the tremendous early success of CELLutions," says Michael Wasserman, vice-president, business development for CELLutions.  "We are working diligently to create a world-class Canadian organization with the ability to bring cutting-edge technology from Canada&#039;s leading academic institutions into widespread use in biopharmaceutical research and development programs around the world.  We intend to use this alliance as a catalyst for further collaborations, with the intent of building a company with the critical technology mass to compete on a global scale."<p><br />
<br />
CELLutions will create and implement targeted marketing strategies to maximize the impact of these high potential technologies, and products will be made available to research groups in both the academia and biopharmaceutical industry.

Media Enquiries

Phone: (905) 525-9140 ext. 24073
Email: comms@mcmaster.ca

The Communications and Public Affairs Office is staffed from 8:30 a.m. to 4:30 p.m. Monday to Friday.

The University has a broadcast quality television studio to facilitate live and pre-recorded interviews with media. Learn more about our experts.